Epilepsy Medication

16 March, 2016

Positive Phase 3 Pivotal Study Results for Epiodiolex (cannabidiol) from GW Pharmaceuticals

By |2023-01-18T15:49:56-05:00March 16th, 2016|Education, Epilepsy Medication, Media|Comments Off on Positive Phase 3 Pivotal Study Results for Epiodiolex (cannabidiol) from GW Pharmaceuticals

London, UK; 14 March 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: “GWP,” “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex® (cannabidiol or CBD) for [...]

2 April, 2014

Sign the Epilepsy Research and Medical Marijuana Petition!

By |2017-05-09T01:58:30-04:00April 2nd, 2014|Advocacy, Awareness, Education, Epilepsy Medication, Legislative, Treatment|Comments Off on Sign the Epilepsy Research and Medical Marijuana Petition!

  The Epilepsy Foundation of America has started a petition on the White House website. We need your help!  We are calling on the President and the Drug Enforcement Administration to reschedule marijuana to a lower level under the controlled substances act.  The Foundation supports this change to benefit greater access to marijuana and its [...]

11 January, 2012

ONFI (clobazam) Tablets now Available in the U.S. at Pharmacies

By |2023-01-18T15:50:01-05:00January 11th, 2012|Epilepsy Medication, Treatment|Comments Off on ONFI (clobazam) Tablets now Available in the U.S. at Pharmacies

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck announced today that ONFI Tablets are now available for prescribing in the United States. The FDA recently approved ONFI for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients two years and older.1 ONFI is an oral anti-epileptic drug (AED) of the benzodiazepine class, and is a 1,5 benzodiazepine.1 ONFI [...]

19 May, 2011

Drug Shortage Alert

By |2017-05-09T13:43:45-04:00May 19th, 2011|Epilepsy Medication|Comments Off on Drug Shortage Alert

Drug Shortage Alert: Pfizer Announces DILANTIN® 30 mg (Extended Phenytoin Sodium Capsules, USP) Shortage The Epilepsy Foundation has learned that Pfizer is contacting health care professionals, including pharmacists, about a shortage of DILANTIN 30 mg. According to Pfizer, this product shortage is due to a manufacturing issue and not the result of any performance or [...]

Go to Top